Cargando…

A novel FOXO1-mediated dedifferentiation blocking role for DKK3 in adrenocortical carcinogenesis

BACKGROUND: Dysregulated WNT signaling dominates adrenocortical malignancies. This study investigates whether silencing of the WNT negative regulator DKK3 (Dickkopf-related protein 3), an implicated adrenocortical differentiation marker and an established tumor suppressor in multiple cancers, allows...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cheng, Joyce Y., Brown, Taylor C., Murtha, Timothy D., Stenman, Adam, Juhlin, C. Christofer, Larsson, Catharina, Healy, James M., Prasad, Manju L., Knoefel, Wolfram T., Krieg, Andreas, Scholl, Ute I., Korah, Reju, Carling, Tobias
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2017
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5333434/ https://www.ncbi.nlm.nih.gov/pubmed/28249601 http://dx.doi.org/10.1186/s12885-017-3152-5

Ejemplares similares

Recurrent Amplification of the Osmotic Stress Transcription Factor NFAT5 in Adrenocortical Carcinoma
por: Brown, Taylor C, et al.
Publicado: (2020)

Gene Expression and Regulation in Adrenocortical Tumorigenesis
por: Fonseca, Annabelle L., et al.
Publicado: (2012)

SLC12A7 alters adrenocortical carcinoma cell adhesion properties to promote an aggressive invasive behavior
por: Brown, Taylor C., et al.
Publicado: (2018)

Whole-Exome Sequencing of Syndromic Adrenocortical Carcinoma Reveals Distinct Mutational Profile From Sporadic ACC
por: Nicolson, Norman G, et al.
Publicado: (2019)

The activating TERT promoter mutation C228T is recurrent in subsets of adrenal tumors
por: Liu, Tiantian, et al.
Publicado: (2014)

Epigenetic silencing of RASSF1A deregulates cytoskeleton and promotes malignant behavior of adrenocortical carcinoma
por: Korah, Reju, et al.
Publicado: (2013)

Transcription Factor Profiling Identifies Spatially Heterogenous Mediators of Follicular Thyroid Cancer Invasion
por: Nicolson, Norman G., et al.
Publicado: (2020)

Human Cytochrome P450 2W1 Is Not Expressed in Adrenal Cortex and Is Only Rarely Expressed in Adrenocortical Carcinomas
por: Nolé, Paola, et al.
Publicado: (2016)

Synchronous aldosterone- and cortisol-producing adrenocortical adenomas diagnosed using CYP11B immunohistochemistry
por: Stenman, Adam, et al.
Publicado: (2019)

TOP2A Expression in Pheochromocytoma and Abdominal Paraganglioma: a Marker of Poor Clinical Outcome?
por: Solhusløkk Höse, Karolina, et al.
Publicado: (2023)

Aberrant DNA repair as a potential contributor for the clonal evolution in subsets of anaplastic thyroid carcinomas arising through dedifferentiation: implications for future therapeutic algorithms?
por: Juhlin, Carl Christofer
Publicado: (2020)

Metastatic-prone telomerase reverse transcriptase (TERT) promoter and v-Raf murine sarcoma viral oncogene homolog B (BRAF) mutated tall cell variant of papillary thyroid carcinoma arising in ectopic thyroid tissue: A case report
por: Stenman, Adam, et al.
Publicado: (2021)

Novel Insights in the Genomics of Anaplastic Thyroid Carcinoma: A Role for Cyclin-Dependent Kinase Inhibition?
por: Stenman, Adam, et al.
Publicado: (2023)

Prognostic Utility of the Ki-67 Labeling Index in Follicular Thyroid Tumors: a 20-Year Experience from a Tertiary Thyroid Center
por: Hellgren, L. Samuel, et al.
Publicado: (2022)

Whole‐exome sequencing defines the mutational landscape of pheochromocytoma and identifies KMT2D as a recurrently mutated gene
por: Juhlin, C. Christofer, et al.
Publicado: (2015)

The Value of Histological Algorithms to Predict the Malignancy Potential of Pheochromocytomas and Abdominal Paragangliomas—A Meta-Analysis and Systematic Review of the Literature
por: Stenman, Adam, et al.
Publicado: (2019)

Over-diagnosis of potential malignant behavior in MEN 2A-associated pheochromocytomas using the PASS and GAPP algorithms
por: Stenman, Adam, et al.
Publicado: (2018)

HRAS mutation prevalence and associated expression patterns in pheochromocytoma
por: Stenman, Adam, et al.
Publicado: (2016)

Clinical Routine TERT Promoter Mutational Screening of Follicular Thyroid Tumors of Uncertain Malignant Potential (FT-UMPs): A Useful Predictor of Metastatic Disease
por: Hysek, Martin, et al.
Publicado: (2019)

Recurrent activating mutation in PRKACA in cortisol-producing adrenal tumors
por: Goh, Gerald, et al.
Publicado: (2014)

GABPA-dependent down-regulation of DICER1 in follicular thyroid tumours
por: Paulsson, Johan O, et al.
Publicado: (2020)

Presentation, Treatment, Histology, and Outcomes in Adrenal Medullary Hyperplasia Compared With Pheochromocytoma
por: Falhammar, Henrik, et al.
Publicado: (2019)

Synchronous lateral lymph node metastases from papillary and follicular thyroid carcinoma: case report and review of the literature
por: Stenman, Adam, et al.
Publicado: (2022)

Papillary Thyroid Carcinoma with Desmoid-Like Fibromatosis: Double Trouble?
por: Juhlin, C. Christofer, et al.
Publicado: (2022)

Adrenal and periadrenal schwannoma: histological, molecular and clinical characterization of an institutional case series
por: Stenman, Adam, et al.
Publicado: (2023)

Shifting patterns of genomic variation in the somatic evolution of papillary thyroid carcinoma
por: Rubinstein, Jill C., et al.
Publicado: (2016)

Nuclear-specific accumulation of telomerase reverse transcriptase (TERT) mRNA in TERT promoter mutated follicular thyroid tumours visualised by in situ hybridisation: a possible clinical screening tool?
por: Hellgren, L Samuel, et al.
Publicado: (2022)

Development of metastatic poorly differentiated thyroid cancer from a sub-centimeter papillary thyroid carcinoma in a young patient with a germline MET mutation – association or random chance?
por: Johansson, Klara, et al.
Publicado: (2021)

Merkel cell polyomavirus T-antigens regulate DICER1 mRNA stability and translation through HSC70
por: Gao, Jiwei, et al.
Publicado: (2021)

A Revised Version of the TNM Classification Leads to Optimized Predictive Performance in Patients with Adrenocortical Carcinoma
por: David, Stephan Oliver, et al.
Publicado: (2023)

Critical role of FOXO3a in carcinogenesis
por: Liu, Ying, et al.
Publicado: (2018)

Genome-Wide and Locus Specific Alterations in CDC73/HRPT2-Mutated Parathyroid Tumors
por: Sulaiman, Luqman, et al.
Publicado: (2012)

Diffuse PTH expression in parathyroid tumors argues against important functional tumor subclones
por: Haglund, Felix, et al.
Publicado: (2016)

Inflammatory infiltrates in parathyroid tumors
por: Haglund, Felix, et al.
Publicado: (2017)

Adrenocortical Carcinoma: Current Therapeutic State-of-the-Art
por: Lebastchi, Amir H., et al.
Publicado: (2012)

Thyroglobulin expression, Ki-67 index, and lymph node ratio in the prognostic assessment of papillary thyroid cancer
por: Lindfors, Helene, et al.
Publicado: (2023)

Pan-Genomic Sequencing Reveals Actionable CDKN2A/2B Deletions and Kataegis in Anaplastic Thyroid Carcinoma
por: Stenman, Adam, et al.
Publicado: (2021)

Involvement of the FOXO6 transcriptional factor in breast carcinogenesis
por: Lallemand, François, et al.
Publicado: (2017)

Minimally invasive follicular thyroid carcinomas: prognostic factors
por: Stenson, Gustav, et al.
Publicado: (2016)

Genetic characterization of large parathyroid adenomas
por: Sulaiman, Luqman, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_68qtv2r4cp8ah2ct5jjd3uk484